TNF-α is associated with loss of lean body mass only in already cachectic COPD patients
| dc.contributor.author | Eagan, Tomas Mikal | en_US |
| dc.contributor.author | Gabazza, Esteban C. | en_US |
| dc.contributor.author | D’Alessandro-Gabazza, Corina | en_US |
| dc.contributor.author | Gil-Bernabe, Paloma | en_US |
| dc.contributor.author | Aoki, Shinya | en_US |
| dc.contributor.author | Hardie, Jon Andrew | en_US |
| dc.contributor.author | Bakke, Per | en_US |
| dc.contributor.author | Wagner, Peter D. | en_US |
| dc.date.accessioned | 2013-05-19T10:37:31Z | |
| dc.date.available | 2013-05-19T10:37:31Z | |
| dc.date.issued | 2012-06-18 | eng |
| dc.Published | Respiratory Research 2012, 13:48 | eng |
| dc.identifier.issn | 1465-9921 | |
| dc.identifier.uri | https://hdl.handle.net/1956/6628 | |
| dc.language.iso | eng | eng |
| dc.publisher | BioMed Central | eng |
| dc.relation.haspart | Background Systemic inflammation may contribute to cachexia in patients with chronic obstructive pulmonary disease (COPD). In this longitudinal study we assessed the association between circulating C-reactive protein (CRP), tumor necrosis factor (TNF)-α, interleukin (IL)-1ß, and IL-6 levels and subsequent loss of fat free mass and fat mass in more than 400 COPD patients over three years. Methods The patients, aged 40–76, GOLD stage II-IV, were enrolled in 2006/07, and followed annually. Fat free mass and fat mass indexes (FFMI & FMI) were calculated using bioelectrical impedance, and CRP, TNF-α, IL-1ß, and IL-6 were measured using enzyme immunoassays. Associations with mean change in FFMI and FMI of the four inflammatory plasma markers, sex, age, smoking, FEV1, inhaled steroids, arterial hypoxemia, and Charlson comorbidity score were analyzed with linear mixed models. Results At baseline, only CRP was significantly (but weakly) associated with FFMI (r = 0.18, p < 0.01) and FMI (r = 0.27, p < 0.01). Univariately, higher age, lower FEV1, and use of beta2-agonists were the only significant predictors of decline in FFMI, whereas smoking, hypoxemia, Charlson score, and use of inhaled steroids predicted increased loss in FMI. Multivariately, high levels of TNF-α (but not CRP, IL-1ß or IL-6) significantly predicted loss of FFMI, however only in patients with established cachexia at entry. Conclusion This study does not support the hypothesis that systemic inflammation is the cause of accelerated loss of fat free mass in COPD patients, but suggests a role for TNF-α in already cachectic COPD patients. | en_US |
| dc.rights | Attribution CC BY | eng |
| dc.rights.uri | http://creativecommons.org/licenses/by/2.0/ | eng |
| dc.title | TNF-α is associated with loss of lean body mass only in already cachectic COPD patients | en_US |
| dc.type | Peer reviewed | |
| dc.type | Journal article | |
| dc.description.version | publishedVersion | en_US |
| dc.rights.holder | 2012 Eagan et al.; licensee BioMed Central Ltd. | |
| dc.identifier.doi | https://doi.org/10.1186/1465-9921-13-48 | |
| dc.identifier.cristin | 997994 | |
| dc.source.journal | Respiratory Research | |
| dc.source.40 | 13 |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as Attribution CC BY